Aversi-Pharma Co Ltd in Retailing (Georgia)

April 2015 | 2 pages | ID: A642319AD6DEN
Euromonitor International Ltd

Abstracts

Over the forecast period, Aversi-Pharma Co Ltd plans to fight for the leadership in OTC and UTC retailing, increasing its own drugstore network and its share of local OTC manufacturing. One of the company’s most successful actions was the establishment of clinic branches.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Non-Store Retailing, Store-based Retailing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Retailing market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Aversi-Pharma Co Ltd: Key Facts
  Summary 2 Aversi-Pharma Co Ltd: Operational Indicators 2011-2013
Internet Strategy
Company Background
Private Label
  Summary 3 Aversi-Pharma Co Ltd: Private Label Portfolio
Competitive Positioning
  Summary 4 Aversi-Pharma Co Ltd: Competitive Position 2014